RGS19 enhances cell proliferation through its C-terminal PDZ motif.

Regulator of G protein signaling 19 (RGS19), also known as Galpha-interacting protein (GAIP), is a GTPase activating protein (GAP) for Galpha(i) subunits. Apart from its GAP function, RGS19 has been implicated in growth factor signaling through binding to GAIP-interacting protein C-terminus (GIPC) via its C-terminal PDZ-binding motif. To gain additional insight on its function, we have stably expressed RGS19 in a number of mammalian cell lines and examined its effect on cell proliferation. Interestingly, overexpression of RGS19 stimulated the growth of HEK293, PC12, Caco2, and NIH3T3 cells. This growth promoting effect was not shared by other RGS proteins including RGS4, RGS10 and RGS20. Despite its ability to stimulate cell proliferation, RGS19 failed to induce neoplastic transformation in NIH3T3 cells as determined by focus formation and soft-agar assays, and it did not induce tumor growth in athymic nude mice. Deletion mutants of RGS19 lacking the PDZ-binding motif failed to complex with GIPC and did not exhibit any growth promoting effect. Overexpression of GIPC alone in HEK293 cells stimulated cell proliferation whereas its knockdown in H1299 non-small cell lung carcinomas suppressed cell proliferation. This study demonstrates that RGS19, in addition to acting as a GAP, is able to stimulate cell proliferation in a GIPC-dependent manner.

[1]  Yan Lu,et al.  RGS17, an overexpressed gene in human lung and prostate cancer, induces tumor cell proliferation through the cyclic AMP-PKA-CREB pathway. , 2009, Cancer research.

[2]  W. Snider,et al.  Selective role for RGS12 as a Ras/Raf/MEK scaffold in nerve growth factor‐mediated differentiation , 2007, The EMBO journal.

[3]  H. Kirikoshi,et al.  Expression of human GIPC1 in normal tissues, cancer cell lines, and primary tumors. , 2002, International journal of molecular medicine.

[4]  S. Pattingre,et al.  Erk1/2-dependent Phosphorylation of Gα-interacting Protein Stimulates Its GTPase Accelerating Activity and Autophagy in Human Colon Cancer Cells* , 2000, The Journal of Biological Chemistry.

[5]  J. Hurst,et al.  Regulator of G-protein signaling (RGS) proteins in cancer biology. , 2009, Biochemical pharmacology.

[6]  Y. Wong,et al.  Involvement of Gi/o Proteins in Nerve Growth Factor-Stimulated Phosphorylation and Degradation of Tuberin in PC-12 Cells and Cortical Neurons , 2005, Molecular Pharmacology.

[7]  M. Farquhar,et al.  The regulator of G protein signaling family. , 2000, Annual review of pharmacology and toxicology.

[8]  J. Jhamandas,et al.  Single Transmembrane Domain Insulin-Like Growth Factor-II/Mannose-6-Phosphate Receptor Regulates Central Cholinergic Function by Activating a G-Protein-Sensitive, Protein Kinase C-Dependent Pathway , 2006, The Journal of Neuroscience.

[9]  H. Bourne,et al.  Mutant α subunits of Gi2 inhibit cyclic AMP accumulation , 1991, Nature.

[10]  J. Hurst,et al.  Regulator of G-protein signalling expression and function in ovarian cancer cell lines , 2008, Cellular & Molecular Biology Letters.

[11]  Y. Wong,et al.  Pertussis toxin-sensitive Gi/o proteins are involved in nerve growth factor-induced pro-survival Akt signaling cascade in PC12 cells. , 2005, Cellular signalling.

[12]  D. Mukhopadhyay,et al.  Expression and regulatory role of GAIP-interacting protein GIPC in pancreatic adenocarcinoma. , 2006, Cancer research.

[13]  F. Beier,et al.  Regulator of G‐protein signaling (RGS) proteins differentially control chondrocyte differentiation , 2006, Journal of cellular physiology.

[14]  G. Blobe,et al.  The type III TGF-beta receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-beta signaling. , 2010, Carcinogenesis.

[15]  C. Kretz-remy,et al.  Human Papillomavirus Type 18 E6 Protein Binds the Cellular PDZ Protein TIP-2/GIPC, Which Is Involved in Transforming Growth Factor β Signaling and Triggers Its Degradation by the Proteasome , 2005, Journal of Virology.

[16]  S. Burchett,et al.  In through the out door: nuclear localization of the regulators of G protein signaling , 2003, Journal of neurochemistry.

[17]  H. M. El-Shewy,et al.  Insulin-like Growth Factors Mediate Heterotrimeric G Protein-dependent ERK1/2 Activation by Transactivating Sphingosine 1-Phosphate Receptors* , 2006, Journal of Biological Chemistry.

[18]  Sun-Hee Kim,et al.  RGS2 promotes formation of neurites by stimulating microtubule polymerization. , 2006, Cellular signalling.

[19]  J. Petrik,et al.  Apoptosis in the pancreatic islet cells of the neonatal rat is associated with a reduced expression of insulin-like growth factor II that may act as a survival factor. , 1998, Endocrinology.

[20]  K. Blumer,et al.  RGS family members: GTPase-activating proteins for heterotrimeric G-protein α-subunits , 1996, Nature.

[21]  A. García-España,et al.  RGSZ1 and GAIP Regulate μ- but Not δ-Opioid Receptors in Mouse CNS: Role in Tachyphylaxis and Acute Tolerance , 2004, Neuropsychopharmacology.

[22]  J. Hepler,et al.  Cellular Regulation of RGS Proteins: Modulators and Integrators of G Protein Signaling , 2002, Pharmacological Reviews.

[23]  Shuying Yang,et al.  RGS10-null mutation impairs osteoclast differentiation resulting from the loss of [Ca2+]i oscillation regulation. , 2007, Genes & development.

[24]  W. Schiemann,et al.  Identification and characterization of regulator of G protein signaling 4 (RGS4) as a novel inhibitor of tubulogenesis: RGS4 inhibits mitogen-activated protein kinases and vascular endothelial growth factor signaling. , 2004, Molecular biology of the cell.

[25]  Zhihui Xie,et al.  RGS16 Inhibits Breast Cancer Cell Growth by Mitigating Phosphatidylinositol 3-Kinase Signaling* , 2009, The Journal of Biological Chemistry.

[26]  J. McCaffery,et al.  RGS-GAIP, a GTPase-activating protein for Galphai heterotrimeric G proteins, is located on clathrin-coated vesicles. , 1998, Molecular biology of the cell.

[27]  R. Fisher,et al.  RGS6 Interacts with SCG10 and Promotes Neuronal Differentiation , 2002, The Journal of Biological Chemistry.

[28]  B. Conklin,et al.  Gz-mediated hormonal inhibition of cyclic AMP accumulation. , 1992, Science.

[29]  Ling Wang,et al.  Targeting GIPC/Synectin in Pancreatic Cancer Inhibits Tumor Growth , 2009, Clinical Cancer Research.

[30]  Chunaram Choudhary,et al.  RGS2 is an important target gene of Flt3-ITD mutations in AML and functions in myeloid differentiation and leukemic transformation. , 2005, Blood.

[31]  Y. Wong,et al.  Identification of a stretch of six divergent amino acids on the alpha5 helix of Galpha16 as a major determinant of the promiscuity and efficiency of receptor coupling. , 2004, The Biochemical journal.

[32]  M. Chao,et al.  GIPC and GAIP form a complex with TrkA: a putative link between G protein and receptor tyrosine kinase pathways. , 2001, Molecular biology of the cell.

[33]  Y. Wong,et al.  Epidermal growth factor differentially augments Gi‐mediated stimulation of c‐Jun N‐terminal kinase activity , 2004, British journal of pharmacology.

[34]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[35]  Y. Wong,et al.  Phosphatidylinositol‐3 kinase is distinctively required for µ‐, but not κ‐opioid receptor‐induced activation of c‐Jun N‐terminal kinase , 2004, Journal of neurochemistry.

[36]  P. Sokoloff,et al.  GIPC recruits GAIP (RGS19) to attenuate dopamine D2 receptor signaling. , 2004, Molecular biology of the cell.

[37]  M. Jensen,et al.  Protein interactions with the glucose transporter binding protein GLUT1CBP that provide a link between GLUT1 and the cytoskeleton. , 1999, Molecular biology of the cell.